Best Growth Stock Right: Lilly vs Vertex Pharmaceuticals
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
Understand the key signals that trigger rebalancing in retirement portfolios to act promptly and protect objectives.
13,093 articlesTwo pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
U.S. stocks slide as oil prices push above $100 a barrel, triggering a risk-off mood that weighs on the S&P 500 and b...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
A federal judge blocked a Pentagon strategy to brand Anthropic as a supply-chain risk and paused a government-wide ba...
As 2026 begins, Tesla faces pressure on deliveries while BYD battles domestic slumps but advances fast charging and o...
Rem’s Mortgage REIT Portfolio surged 19% over the past year as the Fed signaled a slower stance on rates, lifting inc...
The US dollar still dominates oil trades, but signals of strain are rising. Tensions in the Middle East and a push to...